Aldeyra Therapeutics
ALDX
5 hedge funds and large institutions have $6.28M invested in Aldeyra Therapeutics in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
22% more capital invested
Capital invested by funds: $5.16M → $6.28M (+$1.12M)
29% less funds holding
Funds holding: 7 → 5 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
+$80.3K |
| 2 |
Morgan Stanley
New York
|
+$9.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $6.03M | – | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $162K | – | – | – |
|
|
SIM
3
Spark Investment Management
New York
| $77K | +$80.3K | +11,200 | New |
|
|
4
Morgan Stanley
New York
| $9K | +$9.32K | +1,300 | New |
|
|
BIM
5
BlackRock Investment Management
Wilmington,
Delaware
| $2K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$2K | -414 | Closed |
|
|
7
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$2 | -364 | Closed |
|
ALDX Hedge Fund Activity: Q4 2014 in Review
5 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q4 2014, worth a combined $6.28M — up 22% from $5.16M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ALDX and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Spark Investment Management, opening a new position worth an estimated $80.3K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $2K sold.
- 5 institutional investors held Aldeyra Therapeutics (ALDX) as of Q4 2014, down from 7 in Q3 2014.
- Funds reported $6.28M of Aldeyra Therapeutics stock for Q4 2014, up 22% quarter-over-quarter.
- 2 funds opened new Aldeyra Therapeutics positions in Q4 2014 and 3 closed out, a net change of -1 holder.
- The largest Aldeyra Therapeutics buyer in Q4 2014 was Spark Investment Management, an estimated $80.3K added.
- The largest Aldeyra Therapeutics seller in Q4 2014 was Tower Research Capital (TRC), an estimated $2K sold.
Based on aggregated 13F filings for Q4 2014.